Home
About
Technology
Licensing Opportunities
Investors
Education
Events
Contact

Governance Documents

Investors

Overview
News & Events
Company Info
Financial Info
Stock Data
- CSE: LXX
- OTCQX: LXRP
SEC Filings
SEDAR
Governance
- Board of Directors
- Governance Documents

Governance
Board of Directors
Governance Documents

Code of Ethics

Download Code of Ethics

Audit Committee Charter

Download Audit Committee Charter

Email Alerts
Tear Sheet
Contacts
RSS News Feed

Lexaria Bioscience Corp. (CSE:LXX; OTCQX:LXRP) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.

Home
About
Technology
Licensing Opportunities
Investors
News
Blog
Education
Events
Contact

250.765.6424
info@lexariabioscience.com

Lexaria Bioscience Corp.
#100-740 McCurdy Road
Kelowna, BC, V1X2P7

General Disclaimer:
No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases…

Copyright © 2020 All rights reserved. Web Design, Kelowna Photographers, SEO by Hiilite